CN104256844A - 一种缓解疲劳的干混悬剂饮料 - Google Patents
一种缓解疲劳的干混悬剂饮料 Download PDFInfo
- Publication number
- CN104256844A CN104256844A CN201410519420.0A CN201410519420A CN104256844A CN 104256844 A CN104256844 A CN 104256844A CN 201410519420 A CN201410519420 A CN 201410519420A CN 104256844 A CN104256844 A CN 104256844A
- Authority
- CN
- China
- Prior art keywords
- parts
- fatigue
- dry suspension
- suspension drink
- drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000725 suspension Substances 0.000 title abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000013361 beverage Nutrition 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 abstract description 8
- 229940088594 vitamin Drugs 0.000 abstract description 7
- 235000013343 vitamin Nutrition 0.000 abstract description 7
- 239000011782 vitamin Substances 0.000 abstract description 7
- 229930003231 vitamin Natural products 0.000 abstract description 7
- 235000010469 Glycine max Nutrition 0.000 abstract description 6
- 244000068988 Glycine max Species 0.000 abstract description 6
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 6
- 239000011707 mineral Substances 0.000 abstract description 6
- 235000010755 mineral Nutrition 0.000 abstract description 6
- 108010038807 Oligopeptides Proteins 0.000 abstract description 5
- 102000015636 Oligopeptides Human genes 0.000 abstract description 5
- 230000035622 drinking Effects 0.000 abstract description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 abstract description 4
- 229960002666 1-octacosanol Drugs 0.000 abstract description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract description 4
- 229930091371 Fructose Natural products 0.000 abstract description 4
- 239000005715 Fructose Substances 0.000 abstract description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 4
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 abstract description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000008103 glucose Substances 0.000 abstract description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract description 4
- 229940031439 squalene Drugs 0.000 abstract description 4
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 abstract description 4
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 108010024636 Glutathione Proteins 0.000 abstract description 2
- 229960003180 glutathione Drugs 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract description 2
- 235000013619 trace mineral Nutrition 0.000 abstract description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 239000000843 powder Substances 0.000 description 17
- 230000004060 metabolic process Effects 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000003094 microcapsule Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000011149 active material Substances 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000005515 coenzyme Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000005842 biochemical reaction Methods 0.000 description 3
- 150000005693 branched-chain amino acids Chemical class 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 206010020575 Hyperammonaemia Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZIHHMGTYZOSFRC-UWWAPWIJSA-M cobamamide Chemical compound C1(/[C@](C)(CCC(=O)NC[C@H](C)OP(O)(=O)OC2[C@H]([C@H](O[C@@H]2CO)N2C3=CC(C)=C(C)C=C3N=C2)O)[C@@H](CC(N)=O)[C@]2(N1[Co+]C[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C3=NC=NC(N)=C3N=C1)O)[H])=C(C)\C([C@H](C/1(C)C)CCC(N)=O)=N\C\1=C/C([C@H]([C@@]\1(CC(N)=O)C)CCC(N)=O)=N/C/1=C(C)\C1=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]1CCC(N)=O ZIHHMGTYZOSFRC-UWWAPWIJSA-M 0.000 description 2
- 229960005452 cobamamide Drugs 0.000 description 2
- 235000006279 cobamamide Nutrition 0.000 description 2
- 239000011789 cobamamide Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010075016 Ceruloplasmin Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003776 Vitamin B4 Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 229940039229 general nutrients Drugs 0.000 description 1
- 229940031298 glutathione 150 mg Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000021586 packaging of beverage Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
一种缓解疲劳的干混悬剂饮料，由以下重量份数的原料组成：果糖15000-35000、葡萄糖10000-25000、高F值大豆制低聚肽12000-15000、谷胱甘肽100-200、大豆磷脂1500-8000、角鲨烯1000-1500、辅酶Q10400-800、二十八醇30-60，还含有多种水溶性维生素和脂溶性维生素、矿物质常量元素和微量元素、饮用纯净水，本发明具有很好的适口性和稳定性，可以快速缓解疲劳、恢复体能。
Description
技术领域
本发明涉及一种功能饮料，具体地说是一种用于缓解疲劳的干混悬剂饮料。
背景技术
疲劳是人体防止机体发生过度活动、引起生理机能衰竭、对自身生命构成威胁的一种保护性生理反应，是人体复杂的生理生化变化过程的表现。
消除疲劳、恢复体能，除需要休息外，还需要及时补充各种人体需要的营养物质，特别是一些有机活性物质，有时一种或几种有机活性物质对缓解人体的疲劳能起到“四两拔千斤”的作用。
当前市场上抗疲劳的功能饮料很多，但真正有效的并不多，要想研发出更好的产品，就必须依据现代医学、食品学、分子生物学的理论基础，结合现代药剂工业的新工艺、新方法来实现，就是要以分子水平来探讨缓解疲劳食品的开发，从分子水平了解生命现象的本质，了解人体活动所需能量物质以及为能量产生所需要补充的各种营养物质的互相关系，只有把握这种关系，才能做到“有的放矢”，才能做出有效的好产品。
发明内容
本发明的目的，就是根据上述理论提供一种能真正快速缓解疲劳、恢复体能的饮料——干混悬剂饮料。
这种饮料配方中所选用的原料都是人体内生理代谢必须的营养物质或者是代谢中不可缺少的活性物质。这些物质经过口服，迅速被吸收转运，填补了因体内过度消耗能量所造成的营养空缺，同时经过生理代谢能够将过量的有害物质消除，使人体的生理代谢很快恢复到正常的状态，人体疲劳就会消除。
本发明的目的是这样来实现的：
一种缓解疲劳的干混悬剂饮料，其特征是由以下重量份数的原料组成：
根据需要还可以加入食品添加剂(三氯蔗糖、柠檬酸、食用香精、黄原胶等)，使本发明具有适口性和悬浮性、稳定性。
本发明和现有技术相比具有更快速地缓解疲劳、恢复体能的优点。
具体实施方式
将本发明配方中的各种原料简单归类，并以1kg(1000000毫克)饮用纯净水配制成本发明时所用的各种原料的重量及功能叙述如下。
碳水化合物：①，果糖25g，结晶粉末，果糖可直接磷酸化参与糖酵解为机体供能，比葡萄糖吸收速度慢，食用后不会刺激胰岛素大量分泌，出现回跃性低血糖，也不会产生瞬时高血糖，可作为糖尿病患者首选的供能营养物。②，葡萄糖15g，粉末，是人体物质新陈代谢的主要能量来源。
肽：①，高F值大豆制低聚肽13g，粉末，高F值大豆低聚肽，含有大量的三种支链氨基酸(亮氨酸、异亮氨酸、缬氨酸)，这三种氨基酸都是必需氨基酸。支链氨基酸的代谢转变和储存是在肌肉，而其它氨基酸的代谢转变都在肝脏。支链氨基酸能调节肌肉中的糖和能量的水平，并能帮助受伤的肌肉组织痊愈，它们作为肌肉能源的补充，可提高人体活动的能力，同时还能维持氨基酸代谢的平衡。高F值大豆制低聚肽同时还含有丰富的谷氨酸、天门冬氨酸，天门冬氨酸有利于启动三羧循环产生能量。在冠状动脉循环障碍缺氧时，对心肌有保护作用，它参与鸟氨酸循环，促使氨和二氧化碳生成尿素，降低血液中氨和二氧化碳生的含量，增强肝脏功能，消除疲劳。谷氨酸在体内经过代谢能起到解除氨毒的作用，它还参与脑内蛋白质和糖代谢，促进氧化过程，改善中枢神经系统的功能。②，谷胱甘肽150mg，粉末，有解毒作用，对红细胞膜有保护作用，抗过敏，对机体生理代谢有调节作用。
脂类：①，角鲨烯1g，油状液体，广泛存在人的肝脏和脂肪细胞内，参与体内多种生化反应它能提高血清铜蓝蛋白以及超氧化物歧化酶与乳酸脱氨酸的活性。有类似红细胞摄取氧的功能。增加机体氧的利用能力，加快缺氧引起的各种疾病康复。②，辅酶Q10(泛醌)500mg，结晶粉末，广泛存在于人体细胞内，是一种代谢激活剂，能激活细胞呼吸，加速生产腺三磷(ATP)，有增强非特异免疫作用；二十八醇50mg，结晶粉末，能提高机体新陈代谢增加能量产生，增强人的耐力、精力，提高反应灵敏度。③，大豆磷脂1500-8000mg，粉末，对细胞膜的生物活性和机体的新陈代谢有重要调节功能，还能促进细胞活力旺盛，可明显增强人体细胞的免疫功能。
水溶性维生素：①，B1(硫胺素)3mg，粉末，参与糖的代谢和能量代谢，维护神经与消化系统的正常功能。②，活性B2(FAD)50mg，粉末，存在于体内的活性核黄素，广泛参与体内各种氧化还原反应，在生物氧化系统中起传递氢的作用。③，B5(烟酸)50mg，粉末，是许多脱氢酶的辅酶，是生物体中呼吸链的组成部分能促进核酸蛋白质，糖类的合成和代谢。④，B4(磷酸氨基嘌呤)100mg，结晶粉末，本品为核酸和某些辅酶的活性成分，能维持红细胞内ATP水平，延长红细胞的存活时间。⑤，B3(泛酸)3mg，粉末，是辅酶A的重要组成成分，参与各种乙酰化反应包括柠檬酸的形成，丙酮酸的氧化，脂肪酸的合成和氧化等。⑥，B6(吡哆醇)1mg，粉末，作为辅酶参与糖、蛋白质、脂肪代谢，是能量产生，中枢神经系统活动以及血红蛋白生成等必不可少的重要物质。⑦，活性B12(腺苷钴胺)3000μg，粉末，具有抗贫血、抗组胺、护肝、神经保护、蛋白同化、促进生长等作用，比普通B12毒性小，神经亲和性强，造血能力大，活性高，吸收安全。⑧，维C(抗坏血酸)100μg，粉末，能够清除自由基抗氧化，提高免疫力，有防组织出血，促伤口愈合等作用。
脂溶性维生素：①，维A(视黄醇)800μg，油状液体，有保持正常视觉的作用，抗氧化提高免疫力，有调节多种机体代谢的作用。②，维E(生育酚)15μg，油状液体，清除自由基、提高免疫力保持血红细胞完整性，调节体内化合物的合成，降低胆固醇水平，抗动脉硬化。③，硫锌酸100mg，油状液体，作为辅酶参与体内能量代谢，有调节生化反应的联系作用。
矿物质常量元素：①，钙——乳酸钙5g。②，镁——硫酸镁2000μg。③，钾——氯化钾1g。④，钠——氯化钠1g。
矿物质微量元素：①，铁——硫酸亚铁80mg。②，锌——硫酸锌30mg。③，锰——硫酸锰1mg。④，铬——甲基吡啶铬1000μg。⑤，硒——亚硒酸钠200μg。
PH值调节剂：碳酸氢钠2g。
饮用纯净水：1kg(1000000毫克)。
根据需要还可以加入适量的食品添加剂(三氯蔗糖、柠檬酸、食用香精、黄原胶等)，使本发明具有更好的适口性和稳定性。
干混悬剂饮料的制法为，将配方中的活性物质或液态油状物，首先通过喷雾干燥法和喷雾冻凝法制成微囊或肠溶性微囊，粒径在100-500μm。原料中所有的活性物质和会被胃酸破坏的物质都经过微囊技术加工制成肠溶微囊，在肠内消化吸收。制成微囊的方法，目前已有成熟先进工业技术，这里不再论述。
需要制成肠溶微囊的原料有：谷胱甘肽、角鲨烯、辅酶Q10(泛醌)、二十八醇、活性B2(FAD)；
制成微囊的原料有：活性B12(腺苷钴胺)、维A(视黄醇)、维E(生育酚)、硫锌酸。
制成微囊或肠溶微囊后的优点是：提高原料的稳定性；掩盖原料的不良口味；防止原料在胃或肠道内失活，减少对胃肠道的刺激性；使液态物质变固态，便于生产和贮存；减少原料间的配伍影响和变化；有缓释或控释的作用，不用添加任何防腐剂。
将不需制囊的维生素、高F值大豆低聚肽、大豆磷脂、食品添加剂按配方需用量混合在一起，再加入果糖和葡萄糖，进混合机充分混合，过5号筛备用。
剩余的矿物质按配方用量混合在一起，经混合机充分混合，过5号筛备用。
把按配方用量制成的微囊和肠溶微囊混合在一起，加入磷酸三钙(分散剂，可防止微囊粘结在一起)，经混合机混合均匀，过2号筛备用。
将所有混合后的备用原料混合在一起，经混合机充分混合后，过2号筛备用。
上述所有的原料都不溶入水中，而是混合在一起制成粉状的干混悬剂，饮料的包装采用新的包装形式，固(粉料)、液(饮用纯净水)分别装入一个两室联体的瓶中(上室装粉料，下室装饮用纯净水)，服用时顶开中间的密封层，固、液混合，振摇均匀后即可饮用。这样做的好处是：防止了活性物的失活，保持了稳定性；使液态变固态，便于生产，贮存；减少物质配伍变化和相互影响；延长产品的保质期；不需要添加任何防腐剂。
本发明仅限于疲劳人群，少儿、孕妇不宜饮用。
本发明的功能主要是缓解疲劳，包括运动和劳动性疲劳，营养失衡和病理性疲劳，兼有一定的提高非特异性免疫力的作用。
在选用配方物质的成分时，根据导致各种疲劳的多种原因，系统性地进行了综合考虑，从一般的营养物质、糖、脂肪、氨基酸、维生素、矿物质到特殊的生物活性物质如角鲨烯、二十八醇、辅酶Q10等，它们都是人体中广泛或微量存在的必需物质，它们组成了人体各种不同组织和各种不同细胞，他们在人体中所起的作用不同，但它们的作用都是不可缺少的。
在造成疲劳的原因中，主要是营养物质的不足和失衡，一般的营养物质主要还是需要饮食来补充，要尽量做到善食平衡，本配方在能量物质选择上，不是满足供给，只是注意及时快速补充的效果。目前市场上的饮料大都含糖量太高，渗透压高，饮用后停留在胃中时间长，在体内会引起胰岛素的大量分泌，形成回跃性低血糖，以及刺激咽喉，引起胃部不适等感觉，而且太浓的糖需要吸收大量的水，反而会引起干渴。
本配方还有三个特点，一是全面补充人体所需的各种维生素和矿物质，这些物质在体内虽然需要量小，但作用都很大，它们分别是各种生物酶的辅酶或辅基，有的是不同酶的激活剂，它们参与机体各种物质生化反应，并起着相互关联和协同的作用，是人体生命不可缺失的元素。二是本配方选用了不少活性物质，他们也是体内存在的物质，有的参与体内生物代谢过程，有的是酶的激活剂，选用这些活性物质，是为了更好地平衡体内新陈代谢，使各种营养成分被更好的有效利用，使机体的新陈代谢更利于人的各种活动，有目的地补充活性物质，能起到其他补充一般营养物起不到的效果，三是本配方还选用了有利于清除体内高血氨、高二氧化碳、高乳酸的物质，也有水、电解质代谢及酸碱平衡物质，高血氨、高二氧化碳、高乳酸、人体体液的酸碱度失衡等因素也是造成人体疲劳的原因，为此必须同时重视解决这些不利因素。
Claims (1)
1.一种缓解疲劳的干混悬剂饮料，其特征是由以下重量份数的原料组成：
。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410519420.0A CN104256844A (zh) | 2014-10-08 | 2014-10-08 | 一种缓解疲劳的干混悬剂饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410519420.0A CN104256844A (zh) | 2014-10-08 | 2014-10-08 | 一种缓解疲劳的干混悬剂饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104256844A true CN104256844A (zh) | 2015-01-07 |
Family
ID=52148527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410519420.0A Pending CN104256844A (zh) | 2014-10-08 | 2014-10-08 | 一种缓解疲劳的干混悬剂饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104256844A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106942385A (zh) * | 2017-03-23 | 2017-07-14 | 黑龙江省北大荒绿色健康食品有限责任公司 | 一种抗疲劳功能豆乳粉的制备方法 |
| CN107183457A (zh) * | 2017-06-27 | 2017-09-22 | 厦门友和邦生物科技有限公司 | 一种益生菌果汁饮料及其制备方法 |
| CN112471514A (zh) * | 2020-11-27 | 2021-03-12 | 中国农业大学 | 一种促进运动后体能恢复的食品组合物 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1692836A (zh) * | 2005-06-16 | 2005-11-09 | 欧阳康乐 | 一种多元快速补充能量和营养的固体饮料 |
| CN1729875A (zh) * | 2005-08-18 | 2006-02-08 | 北京康比特威创体育新技术发展有限公司 | 一种运动饮料 |
| JP2007111025A (ja) * | 2005-10-20 | 2007-05-10 | Yoshitaka Ito | 紅麹菌等利用甘酒とその製造方法。 |
| CN101214076A (zh) * | 2007-12-28 | 2008-07-09 | 江南大学 | 一种辅酶q10强化型运动饮料及其制备方法 |
-
2014
- 2014-10-08 CN CN201410519420.0A patent/CN104256844A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1692836A (zh) * | 2005-06-16 | 2005-11-09 | 欧阳康乐 | 一种多元快速补充能量和营养的固体饮料 |
| CN1729875A (zh) * | 2005-08-18 | 2006-02-08 | 北京康比特威创体育新技术发展有限公司 | 一种运动饮料 |
| JP2007111025A (ja) * | 2005-10-20 | 2007-05-10 | Yoshitaka Ito | 紅麹菌等利用甘酒とその製造方法。 |
| CN101214076A (zh) * | 2007-12-28 | 2008-07-09 | 江南大学 | 一种辅酶q10强化型运动饮料及其制备方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106942385A (zh) * | 2017-03-23 | 2017-07-14 | 黑龙江省北大荒绿色健康食品有限责任公司 | 一种抗疲劳功能豆乳粉的制备方法 |
| CN107183457A (zh) * | 2017-06-27 | 2017-09-22 | 厦门友和邦生物科技有限公司 | 一种益生菌果汁饮料及其制备方法 |
| CN112471514A (zh) * | 2020-11-27 | 2021-03-12 | 中国农业大学 | 一种促进运动后体能恢复的食品组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100502692C (zh) | 一种体力恢复保健食品及其制备方法 | |
| Engmann et al. | Proximate and mineral composition of snail (Achatina achatina) meat; any nutritional justification for acclaimed health benefits | |
| JPWO2005023021A1 (ja) | ダイエット食品 | |
| Cui et al. | Advances in sports food: Sports nutrition, food manufacture, opportunities and challenges | |
| EP1178740A1 (en) | New composition | |
| CN102793163A (zh) | 一种钙铁锌硒多维咀嚼片及其制备方法 | |
| CN106061292A (zh) | 强化的微量营养素盐调配物 | |
| CN104509919A (zh) | 一种功能性营养素饮料 | |
| Espinosa-Salas et al. | Nutrition: Micronutrient Intake, Imbalances, and Interventions | |
| CN107048137A (zh) | 一种适用于慢性肾病患者的低磷乳清蛋白粉及其制备方法 | |
| CN108391811A (zh) | 一种肿瘤全营养配方食品及其应用 | |
| CN104256844A (zh) | 一种缓解疲劳的干混悬剂饮料 | |
| CN103431392A (zh) | 一种供糖尿病患者食用的复合海洋特膳食品 | |
| CN104256588A (zh) | 一种特殊医学用途配方食品均衡营养液及其制备方法 | |
| CN108013299A (zh) | 补充体能饮料 | |
| CN105072925A (zh) | 用于改善新生婴儿认知、脑和/或cns发育的组合物和使用其的方法 | |
| CN109475513A (zh) | 提升运动能力的能量组合物 | |
| US8440241B1 (en) | Alcohol metabolizing assisting supplement | |
| CN111227241B (zh) | 一种补充全营养的组合物及其制备方法 | |
| CN102292082A (zh) | 对抗环境应激作用、提高免疫和改善精力同时解决维生素和矿物质缺乏且不具有大剂量的营养补充剂的副作用的多种维生素/矿物质制剂 | |
| KR20080008155A (ko) | 한국인에게 특별히 필요한 비타민, 무기질, 또는 발효시킨천연물을 함유하는 영양제 조성물 | |
| CN103621871B (zh) | 一种复合氨基酸保健品及其制备方法 | |
| CN102334683A (zh) | 一种改善记忆的保健饮品组合物及其制备方法 | |
| US11077085B2 (en) | Dietary macro/micronutritional supplement for patients undergoing kidney dialysis | |
| US8440242B1 (en) | Alcohol metabolizing assisting supplement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DD01 | Delivery of document by public notice |
Addressee: Liu Yonghong Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150107 |